Rehmann Capital Advisory Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Rehmann Capital Advisory Group’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-73	Closed	-$1K	–	2308
2018 Q1	$1K	Buy	+73	New	+$1.43K	﹤0.01%	1987

Rehmann Capital Advisory Group's IPXL Position: Q2 2018 in Review

Rehmann Capital Advisory Group sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 73 shares — an estimated $1K sold.

Rehmann Capital Advisory Group first reported a position in IPXL in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Rehmann Capital Advisory Group reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Rehmann Capital Advisory Group sold 73 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1K.
Rehmann Capital Advisory Group first reported a position in Impax Laboratories, Inc. in Q1 2018 and held it in 1 quarter.
Rehmann Capital Advisory Group's Impax Laboratories, Inc. position peaked at $1K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Rehmann Capital Advisory Group's 13F filing for Q2 2018, filed 20 Sep 2018.